Matthew A. Held

1.5k total citations
23 papers, 1.0k citations indexed

About

Matthew A. Held is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Matthew A. Held has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Immunology. Recurrent topics in Matthew A. Held's work include Melanoma and MAPK Pathways (4 papers), Immunotherapy and Immune Responses (4 papers) and Protein Degradation and Inhibitors (3 papers). Matthew A. Held is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Immunotherapy and Immune Responses (4 papers) and Protein Degradation and Inhibitors (3 papers). Matthew A. Held collaborates with scholars based in United States, Switzerland and Australia. Matthew A. Held's co-authors include Lee A. Denson, Alan Bohan, James L. Boyer, Marcus Bosenberg, Wensheng Chen, Ram K. Menon, Grier P. Page, Shelley D. Smith, Jeffrey R. Gruen and Haiying Meng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Matthew A. Held

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew A. Held United States 14 376 342 266 259 126 23 1.0k
Juntao Ke China 25 845 2.2× 208 0.6× 67 0.3× 266 1.0× 189 1.5× 75 1.5k
Katherine E. Lewis United States 12 176 0.5× 28 0.1× 122 0.5× 15 0.1× 166 1.3× 24 744
Pavlo Lutsik Germany 21 1.2k 3.2× 151 0.4× 25 0.1× 367 1.4× 91 0.7× 44 1.7k
Baoguang Han United States 16 707 1.9× 87 0.3× 5 0.0× 84 0.3× 60 0.5× 26 1.1k
Shijie Zheng China 15 1.1k 3.0× 80 0.2× 18 0.1× 217 0.8× 38 0.3× 27 1.4k
Sara Kangaspeska Finland 9 1.1k 2.8× 98 0.3× 12 0.0× 239 0.9× 39 0.3× 13 1.3k
Goeril Karlsson Switzerland 10 754 2.0× 155 0.5× 15 0.1× 18 0.1× 69 0.5× 30 1.6k
Diyu Chen China 12 653 1.7× 90 0.3× 23 0.1× 14 0.1× 51 0.4× 29 1.0k
L Wasserman United States 17 661 1.8× 535 1.6× 4 0.0× 189 0.7× 103 0.8× 30 1.4k

Countries citing papers authored by Matthew A. Held

Since Specialization
Citations

This map shows the geographic impact of Matthew A. Held's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Held with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Held more than expected).

Fields of papers citing papers by Matthew A. Held

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Held. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Held. The network helps show where Matthew A. Held may publish in the future.

Co-authorship network of co-authors of Matthew A. Held

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Held. A scholar is included among the top collaborators of Matthew A. Held based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Held. Matthew A. Held is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Held, Matthew A., Emily Greenfest‐Allen, Su Su, et al.. (2020). Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling. Cellular Signalling. 69. 109554–109554. 8 indexed citations
2.
Held, Matthew A., Emily Greenfest‐Allen, Christian J. Stoeckert, et al.. (2020). Phospho-proteomic discovery of novel signal transducers including thioredoxin-interacting protein as mediators of erythropoietin-dependent human erythropoiesis. Experimental Hematology. 84. 29–44. 11 indexed citations
3.
Langdon, Casey G., James T. Platt, Robert E. Means, et al.. (2017). Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor. Molecular Cancer Therapeutics. 16(6). 1041–1053. 12 indexed citations
4.
Wali, Vikram B., Casey G. Langdon, Matthew A. Held, et al.. (2016). Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer. Cancer Research. 77(2). 566–578. 38 indexed citations
5.
Wojchowski, Don M., et al.. (2016). "C1ORF150", a Novel Mediator of EPO/EPOR/JAK2 Dependent Human Erythroid Progenitor Cell Formation. Blood. 128(22). 544–544.
6.
Theodosakis, Nicholas, Matthew A. Held, Katrina Meeth, et al.. (2015). BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume. Molecular Cancer Therapeutics. 14(7). 1680–1692. 29 indexed citations
7.
Langdon, Casey G., Matthew A. Held, James T. Platt, et al.. (2015). The broad‐spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF ‐mutant melanoma cells in combination with other signaling pathway inhibitors. Pigment Cell & Melanoma Research. 28(4). 417–430. 13 indexed citations
8.
Langdon, Casey G., Norbert Wiedemann, Matthew A. Held, et al.. (2015). Abstract 2529: Debio 1143 synergizes with taxanes, topoisomerase and bromodomain inhibitors to inhibit growth of lung adenocarcinoma. Cancer Research. 75(15_Supplement). 2529–2529. 1 indexed citations
9.
Held, Matthew A., Casey G. Langdon, James T. Platt, et al.. (2012). Genotype-Selective Combination Therapies for Melanoma Identified by High-Throughput Drug Screening. Cancer Discovery. 3(1). 52–67. 96 indexed citations
10.
Gentry, J. Eric, et al.. (2011). Traumatic loss and natural disaster: A case study of a school-based response to Hurricanes Katrina and Rita. School Psychology International. 32(5). 553–566. 15 indexed citations
11.
Held, Matthew A., David P. Curley, David Dankort, et al.. (2010). Characterization of Melanoma Cells Capable of Propagating Tumors from a Single Cell. Cancer Research. 70(1). 388–397. 73 indexed citations
12.
Tighe, Scott & Matthew A. Held. (2010). Isolation of Total RNA from Transgenic Mouse Melanoma Subsets Using Fluorescence-Activated Cell Sorting. Methods in molecular biology. 27–44. 10 indexed citations
13.
Held, Matthew A. & Marcus Bosenberg. (2010). Genetic alterations in malignant melanoma. Diagnostic histopathology. 16(7). 317–320. 3 indexed citations
14.
He, Jiman, Erin Bonkowski, Xiaonan Han, et al.. (2005). Tumor Necrosis Factor α Blockade Restores Growth Hormone Signaling in Murine Colitis. Gastroenterology. 128(5). 1278–1291. 51 indexed citations
15.
Meng, Haiying, Shelley D. Smith, Karl Hager, et al.. (2005). DCDC2 is associated with reading disability and modulates neuronal development in the brain. Proceedings of the National Academy of Sciences. 102(47). 17053–17058. 310 indexed citations
16.
Meng, Haiying, Karl Hager, Matthew A. Held, et al.. (2005). TDT-association analysis of EKN1 and dyslexia in a Colorado twin cohort. Human Genetics. 118(1). 87–90. 59 indexed citations
17.
Held, Matthew A., et al.. (2004). Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 288(5). G986–G993. 14 indexed citations
18.
Bohan, Alan, Wensheng Chen, Lee A. Denson, Matthew A. Held, & James L. Boyer. (2003). Tumor Necrosis Factor α-dependent Up-regulation of Lrh-1 and Mrp3(Abcc3) Reduces Liver Injury in Obstructive Cholestasis. Journal of Biological Chemistry. 278(38). 36688–36698. 128 indexed citations
19.
Denson, Lee A., Matthew A. Held, Ram K. Menon, et al.. (2003). Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. American Journal of Physiology-Gastrointestinal and Liver Physiology. 284(4). G646–G654. 77 indexed citations
20.
Denson, Lee A., Alan Bohan, Matthew A. Held, & James L. Boyer. (2002). Organ-specific alterations in RARα:RXRα abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis. Gastroenterology. 123(2). 599–607. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juntao Ke Breakdown of academic impact, for papers by Katherine E. Lewis Breakdown of academic impact, for papers by Pavlo Lutsik Breakdown of academic impact, for papers by Baoguang Han Breakdown of academic impact, for papers by Shijie Zheng Breakdown of academic impact, for papers by Sara Kangaspeska Breakdown of academic impact, for papers by Goeril Karlsson Breakdown of academic impact, for papers by Diyu Chen Breakdown of academic impact, for papers by L Wasserman
Rankless by CCL
2026